TP53 and glioblastoma: Here, we investigate the relationship between DAXX and ATRX loss of function and p53 DNA-damage sensing pathway using sets of syngenic glioblastoma cell lines with CRISPR/Cas9 knockout of DAXX or ATRX that have acquired ALT-like features relative to parental controls.